Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board remands the claims for service connection for lumbosacral strain, right ankle tendonitis, and dermatitis to correct duty-to-assist errors.

The Board granted service connection for tinnitus and dermatitis, finding that both conditions are related to the Veteran's active duty service.

The Board granted earlier effective dates of August 5, 2021, for the grant of service connection for sinusitis and dermatitis under the PACT Act.

The Board denied the Veteran's claims for increased ratings for tinnitus, atrioventricular (AV) block, left knee patellofemoral pain syndrome, and tinea pedis.

The Board granted the Veteran's appeal for an annual clothing allowance for 2021 due to damage caused by Clindamycin Benzoyl Peroxide 1 to 3 percent topical gel used to treat a service-connected disability.

The Board denied a compensable rating for tinea unguium and restored the 20 percent disability evaluation for chronic pain syndrome.

The Board granted service connection for nummular eczema, finding that new and relevant evidence was submitted and the Veteran's symptoms were related to his in-service skin conditions.

The Board denied service connection for acne and remanded several claims, while granting a 10 percent rating for the headache condition from April 11, 2022, to May 5, 2023.

The Board denied a compensable rating for pseudofolliculitis barbae but granted service connection for migraines.

The Board remands the claim for an increased initial rating for a skin disability, including chronic dermatitis, tinea pedis, xerosis and hyperkeratosis, to obtain additional medical evidence regarding systemic therapy and the degree of involvement of nonservice-connected disabilities.

The Board dismissed the veteran's appeals for an increased rating and service connection due to procedural defects in his October 23, 2024, appeal.

The Board dismissed the appeal for service connection for multiple conditions, including Parkinson's disease, diabetes mellitus type 2, and others.

The Board granted service connection for migraines and bilateral hand tremors as MUCMIs, restored a 30 percent rating for irritable bowel syndrome (IBS), and denied increased ratings for restless leg syndromes and pseudofolliculitis barbae.

The Board granted service connection for hypertension but denied it for pseudofolliculitis barbae.

The Board denied service connection for a right eye disorder and remanded several other issues, while granting restoration of the 30 percent evaluation for migraines effective from April 5, 2023.

The Board denied a compensable disability rating for pseudofolliculitis barbae but granted a 10 percent disability rating for painful scars.

The Board remands the issue of entitlement to an initial compensable rating for pseudofolliculitis barbae (PFB) due to an inadequate examination.

The Board denied the veteran's claims for earlier effective dates and a higher initial disability rating, as well as the claim for special home adaptation.

The appeal for a compensable rating for tinea pityriasis has been withdrawn by the Veteran.

The Board granted service connection for tinea pedis and remanded the claim for psoriasis due to further development.